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ABSTRACT
The immunohistochemical detection of the
thymidine analog, 5-bromo-2’-deoxyuridine
(BrdU) is shown to be a useful and reliable
method to positively identify fetal brain trans-
plants in standard histological preparations.
This technique offers several advantages over
the [3H]thymidine autoradiographic method,
including being much more rapid and avoiding
the use of radionuclides.
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While the transplantation of neuronal and
non-neuronal tissue into the CNS has become
rather commonplace, no generally recognized
standards for the histological identification of
transplanted tissues have been established. In
some instances, of course, the histological verifi-
cation of the transplant is unnecessary, or, in-
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deed, precluded by the experimental design, and
in others, localization of the transplant may be
possible due to some identifying feature of the
transplanted cells, such as a cell-specific, tissue-
specific or (in the case of xenografts) strain- or
species-specific marker or due to the presence of
an introduced marker such as a retrogradely
transported fluorescent dye/15,16/. Yet in many
cases, the identification of transplants has relied
solely on their appearance in routine cell-stained
preparations- an unreliable procedure for ho-
motopic CNS transplants, especially when fetal
brain tissue is transplanted into the developing
brain. Some studies have employed the generally
applicable technique of autoradiographically
identifying donor tissue prelabeled with
[3H]thymidine/6,7,11,14/. Although this method
is very reliable and useful it has not been widely
adopted, probably because it is expensive and
time-consuming and, of course, necessitates 11
of the precautions attendant to the in vivo use of
a radionuclide. During the past several years
many studies on the kinetics of cellular prolifera-
tion have relied on the use of the thymidine
analog, 5-bromo-2’-deoxyuridine (BrdU), which
can be detected immunohistochemically/8/. Re-
cently, this method has been shown to be useful
for labeling proliferating neuronal populations
/9,10/. We now report that BrdU can be a useful
marker for the unequivocal identification of
brain transplants in routine histological sections.
Albino Sprague-Dawley rats obtained from
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Charles River were bred in our colony. The
morning when the vaginal wash was found to be
sperm-positive was designated embryonic day
(E) 0. On E15 the pregnant rat was given a single
intraperitoneal injection of BrdU (2ml/100 g
body weight of labeling agent from the Cell Pro-
liferation Kit obtained from Amersham, U.K.;
equivalent to 60 mg BrdU/kg body weight). Two
days later the pregnant rat was anesthetized with
chloral hydrate (300mg/kg body weight) and the
fetuses were removed. The fetal brains were dis-
sected into Ham F10 medium (Biofluids, Inc.,
Rockville, MD). A piece of either the occipital
(n=4) or frontal (n=-6) cortex was dissected
from each fetal brain, and trimmed further be-
fore transplantation. Newborn (P0) host animals
were anesthetized by hypothermia. The scalp
was incised and a bone flap made over the oc-
cipital cortex. A hole was made in the host oc-
cipital cortex by aspiration, the donor tissue was
placed into the hole and the bone flap replaced.
The scalp incision was closed and the rat pups
were allowed to recover from anesthesia on a
heating pad before returning to the dam. The
host animals were weaned after the third postna-
tal week and were killed at 33 to 38 days of age.
For this, all of the animals were deeply anes-
thetized with chloral hydrate; four were decapi-
tated and their brains were quickly removed and
frozen for cyrostat sectioning; three were per-
fused through the ascending aorta with 0.9%
NaC1 and their brains were removed and placed
into Carnoy’s solution for paraffin embedding;
and three were perfused through the ascending
aorta with 0.9% NaC1, followed by 10% formalin
in 0.1M phosphate buffer and their brains were
placed in 15% sucrose in 10% buffered formalin
for frozen sectioning. Some of these animals had
2 to 7 days previously received an injection of a
retrograde tracer (0.2/xL of 2% fast blue or flu-
oro gold) into the cortex contralateral to the
transplant. The brains were processed as rec-
ommended in the Amersham Cell Proliferation
Kit (Amersham, U.K.), with some modifications.
Briefly, the slide-mounted sections were hy-
drated (paraffin sections were first de-waxed in
xylene), treated with 0.07N NaOH for 2 min. and
washed in PBS, before being covered with a
monoclonal anti-BrdU antibody (Cell
Proliferation Kit, Amersham, U.K.) and placed
in a humidified box for 40-48 hours. The sections
were then exposed to a peroxidase conjugated
anti-mouse IgG and reacted in the presence of
hydrogen peroxide and 3,3’-diaminobenzidine
tetrahydrochloride, together with cobalt chloride
and nickel chloride. Following the peroxidase
reaction the sections were dehydrated, defatted
in xylene, rehydrated, intensified in 0.005%
OsO4, and eoverslipped. An adjacent series of
sections was routinely counterstained with
thionin, and some of the immunoreacted sections
were thionin eounterstained before cover-
slipping.
In the neocortex of the E17 fetal donor brains
large numbers of BrdU-immunoreactive cells are
present both in the proliferative matrix lining the
lateral ventricles, the ventricular zone/3/, and in
the cortical plate where they had presumably mi-
grated after their terminal mitosis (Fig. 1). This
distribution is essentially identical to that seen at
this fetal stage after an E15 injection of
[3H]thymidine/11/. This confirms the oreviouslv
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Fig. 1:This is an uneounterstained sacjcjital section
through one o1: the l:etal donor brains. P,ostral is
to the right. The large oLIrvd arrows indicate
the recjion o rostral cortex which was removed
and urther trimmed prior to transplantation.
{The host brain into which cortex 1:tom this donor
was transplanted is shown in Ficj. 2 0 8, D). Note
that BrdU-immunoreactive cortical cells are
ound in the ventricular/subventricular zone
and in the cortical plate (:), but that few are
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noted correspondence in both the presence and
distribution of labeled cortical cells using
[3H]thymidine autoradiography or BrdU-im-
munohistochemistry/9/.
In the host animals the clearest delimitation
of the transplants is seen in the Carnoy’s fixed
paraffin sections in which optimal immunohisto-
chemistry was obtained. A BrdU-labeled trans-
plant was identified in all four of these animals.
Sections from three of these cases are shown in
Figure 2. The appearance of the labeled trans-
plants.appears comparable to the labeling which
Fig. 2:These photomicrographs are of frontal sec-
tions through the occipital cortex from three
different transplant cases. Two O#m thick
paraffin sections are shown for each case: one
Nissl-stained with thionin r&,C & E) and an adja-
cent one processed for BrdU-immunohisto-
chemistry (B,D & F, respectively). A and B are
from a case in which a piece of fetal rostral
cortex was transplanted to an occipital locale. In
A it can be seen that in the region of the trans-
plant the cortical cytoarchitecture is disrupted
and the cell-poor layer is absent (between the
arrows), and the distribution of BrdU-immunore-
active cells in B indicates that this is indeed the
transplant. C and D are from another rostral-to-
occipital cortical transplant case. As is shown in
C the Nissl-stained appearance of the cortex
suffered only minor disruption in the region of
the transplant, and layer is present, yet ,,le
presence of a wedge-shaped transplant is indi-
cated in the adjacent section shown in D. E and
F are from a homotopic transplant case in which
a piece of occipital cortex was placed into oc-
cipital cortex. There is some disruption of the
cortical cytoarchitecture as seen in E, and as in
the case shown in A & B, layer is absent
(between the arrows), yet the distribution of
BrdU-immunoreactive cells in the adjacent sec-
tion (F) indicates that most of the disrupted
cortex is host cortex and the transplanted piece
of cortex is only the group of cells between the
arrowheads. The small clump of cells beneath
the transplant (*) is not immunoreactive, and
indeed examination of more rostral sections in-
dicates that this is a piece of the host dentate
gyrus granule cell layer. Bar 0.5 mm.138 D.B. Brown & Brent B. Stanfield
is obtained using [3H]thymidine as a marker of
the transplant /11,14/. Certainly the density of
BrdU-immunoreactive cells within the trans-
plants is as great, if not greater, than what is
found in transplants taken from fetuses exposed
to a single dose of [3H]thymidine. It should not
be surprising that BrdU may provide a more sen-
sitive marker than [3H]thymidine, since the short
penetrance of the/3-particles emitted by tritium
allows the photographic emulsion layer of an au-
toradiogram to sample only the upper few mi-
crons of the section/12/, while BrdU-immunore-
active cells can be labeled throughout even a
30/xm thick section/9/. As in autoradiograms of
[3H]thymidine-labeled transplants, the distribu-
tion of the BrdU-immunoreactive cells is some-
times skewed, with one part of the transplant
having a greater density of labeled cells than an-
other part. As has previously been suggested for
[3H]thymidine-labeled transplants /11/, this dis-
tribution of labeled cells may reflect a partial re-
tention of the laminar organization of the trans-
planted cortex, and hence of the inside-out radial
gradient in the time of origin of its constituent
neurons/4/.
The effectiveness of the BrdU method in pro-
viding positive identification of cortical trans-
plants is especially apparent when Nissl-stained
sections are compared with adjacent sections
processed for BrdU-immunohistochemistry. Of-
ten the cellular organization of the cortex as seen
in Nissl-stained sections is disrupted in the region
of the transplant and the cell-poor layer I may be
absent (Fig. 2A,E). Occasionally however, the
region of the transplant has a layer I and distor-
tion of the cortex is minimal (Fig. 2C). Adjacent
sections processed for BrdU-immunohistochem-
istry indicate that while the distorted area of cor-
tex which lacks a layer I may correspond to the
transplant (Fig. 2B), this is not always the case
(Fig. 2F), and that the transplant may, in fact, be
present in a region with minimal distortion which
may not be apparent in the Nissl-stained section
(Fig. 2D).
These observations indicate that Nissl-stained
sections alone do not allow for the positive iden-
tification of fetal brain tissue transplanted into
the developing brain, but that BrdU provides a
reliable marker for fetal brain transplants and of-
fers a number of advantages over [3H]thymidine
autoradiography. First, it takes only a few days to
process tissue with the BrdU method, while the
exposure time alone for [3H]thymidine autora-
diography is typically a month or more. Second,
the BrdU method avoids all of the precautions
and monitoring necessary for the in vivo use of
radionuclides. Third, the BrdU method requires
no special equipment or facilities other than
what is available in a standard histology labora-
tory, while autoradiography requires a darkroom
with controlled temperature and humidity.
Fourth, the BrdU method is relatively inexpen-
sive. Finally, a BrdU method kit is commercially
available (Cell Proliferation Kit, Amersham,
U.K.).
There are, however, some disadvantages to
the BrdU method. First, BrdU can be cytotoxic
/2/, and in some species developing neurons
which incorporate BrdU, subsequently die/1,5/.
Thus, while BrdU does not appear to be
cytotoxic at the doses we have used/9/, higher
doses or multiple doses of BrdU may affect the
viability of the transplant. Second, the efficacy of
the method is sensitive to the method of tissue
fixation/13/. While consistent and reliable results
were obtained with Carnoy’s fixation, we were
unable in our formalin perfused frozen material
to produce satisfactory results with the
immunohistochemistry while preserving the
retrogradely transported dye labeling in the
same sections. The method may not then be
compatible with certain fixation parameters. But
in many instances the BrdU method offers a
rapid, reliable and sensitive technique for the
definitive identification of transplanted fetal
brain tissue.
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